Calidi Biotherapeutics, Inc. (CLDI): Cash & Equivalents
$9.60M
As of 2024-12-31
+108.3%
3-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2024-12-31 | $9.60M | n/a | 2025-03-31, Balance as of period end |
| No annual figure between 2021-12-31 and 2024-12-31. | |||
| 2021-12-31 | $1.06M | n/a | 2022-03-31, Balance as of period end |